Marching Toward Innovation: Prospectus Filed for 'New Horizons in Medical Devices' Product Showcase
In the field of modern medicine, the development of innovative medical devices is reshaping the landscape of treatment and diagnosis at an unprecedented pace. With continuous technological innovation and iteration, these cutting-edge products are not only playing a crucial role in improving the efficiency and precision of disease treatment but are also leading a disruptive transformation. Fortunately,November 21heldJiading Industrial Park Medical and Health Industry Summit & United Imaging Town Development and Construction PromotionLet us take this opportunity to meet these innovative products. Before the official unveiling, why not get a sneak peek at the “top performers” in various niche segments of the medical device industry?
The company’s innovatively developed EA-II exoskeleton rehabilitation robot has successfully obtained Shanghai’s first Class II medical device registration certificate for a lower-limb walking machine-assisted training device. Weighing only 23 kg, the device features precision mechanical connectors and adjustable joint modules that not only ensure a close fit to the patient’s body structure but also simulate multi-degree-of-freedom movements of human joints. This highly conformable design fundamentally addresses potential safety hazards associated with traditional exoskeletons, while enhancing wearing comfort and freedom of movement.
The company’s innovatively developed biodegradable magnesium metal closure clip is the first of its kind in China to receive approval from the National Medical Products Administration (NMPA). After implantation, the clip is absorbed by the patient’s body over time and does not remain permanently. This product fills a previous technological gap in this field within China, delivering significant clinical benefits to patients.
An innovation-driven digital color Doppler ultrasound equipment company, its products boast excellent performance and rich cutting-edge features, breaking through the entry barriers of top-tier (Grade A tertiary) hospitals. The product innovation point “URM Super-Resolution Microscopic Imaging Technology” breaks through the limitations of traditional ultrasound imaging, achieving unprecedented 20-micron-level imaging of microcirculation and microvasculature. The ultrasound product matrix is complete, with multiple best-selling products such as the ULTIMUS 9E flagship series color Doppler ultrasound, VINNO 10 high-end portable color ultrasound diagnostic instrument, and VINNO P wireless handheld color ultrasound diagnostic instrument.
The company has more than 20 marketed products. Its flagship product, the fully wireless high-pressure injector, features innovative designs such as RAY wireless technology, dual-mode power supply, and dual-mode communication. Products such as the ultraviolet disinfection cart and medical radiation protection curtain hold exclusive invention patents.
The company’s high-end innovations, including digital subtraction angiography (DSA) systems, interventional surgical robots, all-in-one mobile C-arm X-ray machines, and AI-powered intelligent imaging processing platforms, not only align with advanced international technical standards but also significantly enhance the quality and efficiency of medical services in practical applications. Notably, the “haptic perception” feature of its vascular interventional surgical robot achieves pressure sensitivity comparable to the sensation of holding a coin in the palm of one’s hand.
In the “Human-Machine Challenge,” the top-scoring AI-assisted diagnostic system for digestive endoscopy, “EndoGenie,” leverages artificial intelligence to extend beyond the limits of human visual acuity and manual dexterity. It not only reduces blind spots during digestive endoscopic procedures but also enhances early cancer detection capabilities, enabling the sensitive capture of lesions as fine as a hair strand, thereby preventing missed examinations and misdiagnoses.
The company’s independently developed, internationally original technology, “Combo Knife,” eliminates the need for open surgery. By utilizing an ablation needle with a diameter of approximately two millimeters, it destroys tumors through extreme temperature differentials of nearly 300°C between cryoablation and thermal ablation. The technology has been implemented in more than 200 hospitals across China, breaking the long-standing reliance on imported products in the field of minimally invasive tumor intervention. It has also obtained EU CE certification and been designated as a Breakthrough Device by the U.S. FDA.
The company’s independently developed bio-3D-printed regenerative bone repair product has revolutionized the field by addressing critical clinical limitations of traditional synthetic bone substitute materials, such as unstable space maintenance, susceptibility to dispersion, poor shapeability, and high complication rates. This product not only achieves mechanical compatibility through its composition and precisely tunable pore structure to promote new bone regeneration, but also allows for the design of degradation rates that match the pace of new bone formation, thereby optimizing repair outcomes. By balancing standardized manufacturing with personalized customization, the product demonstrates strong innovativeness and significant clinical application value.
The company’s self-developed intracoronary shockwave therapy system has officially received marketing approval from the National Medical Products Administration (NMPA). It is currently the only domestically developed and patented intracoronary shockwave therapy product in China that has successfully overcome the technical bottlenecks associated with foreign counterparts. Puchuang Medical is also a leading domestic enterprise in the field of intracoronary shockwave therapy.
The world’s only company capable of stable, mass-produced carbon nanotube “cold cathode” distributed X-ray sources. Leveraging the superior electrical conductivity and field emission properties of carbon nanotubes, the company has successfully developed a “cold cathode” X-ray source. This innovative technology effectively addresses numerous issues associated with the “high temperatures” generated by traditional X-ray sources, representing a major breakthrough in materials science and imaging technology, as well as a significant milestone in the century-long development of X-ray technology. Building on this foundation, XinHong Electronics further capitalized on the exceptional characteristics of carbon nanotube cathodes to develop a multi-focal distributed X-ray source. By arranging X-ray sources in an array and sequentially emitting beams through electronic control, the system can acquire detailed static 3D images without any mechanical movement. XinHong Electronics has applied this innovative achievement across various fields, including healthcare, dentistry, security screening, and industrial non-destructive testing.
As a pan-vascular interventional innovation enterprise, Zhongtian Medical leverages its “full-stack in-house R&D” technological capabilities to build disease-centric, one-stop solutions in the field of neurointervention for acute ischemic stroke, intracranial arterial stenosis, and carotid artery stenosis. In the realm of peripheral intervention, the company has deployed innovative products in key areas such as peripheral thrombus removal, treatment of venous stenosis, peripheral embolization therapy, and treatment of carotid artery stenosis, with its carotid artery stent having entered the “green channel” for special review of innovative medical devices.
On November 21, 2024, more than ten exhibitors will gather at the Jiading Industrial Park Medical and Health Industry Summit and United Imaging Town Development and Construction Promotion Event, showcasing their professional expertise. We look forward to meeting you there!
Event Date: November 21, 2024
Event Venue: Sheraton Shanghai Jiading Hotel
1Over 50 Industry Leaders Gather:
The event will feature invited guestsAcademicians of the Chinese Academies, renowned experts from top-tier tertiary hospitals, core executives of United Imaging Healthcare, key leaders from government functional departments, representatives from upstream and downstream enterprises in the medical imaging industry, representatives from implantable and interventional device manufacturers, overseas expansion service providers, and representatives from financial securities and investment institutionsWith over 50 distinguished guests in attendance.
23 Major Hot Topics:
CoverageMedical Imaging Equipment, Implantable and Interventional Devices, Corporate Global ExpansionCentered around three key hot topics, Sub-forum 1 will focus on innovative development in the medical imaging equipment industry, where United Imaging Healthcare is a major player, sharing the latest industry trends and technological breakthroughs. Sub-forum 2 will concentrate on frontier innovations in implantable and interventional medical devices, exploring development trends and market potential in this field. Sub-forum 3 will keep pace with the wave of international expansion in the industry by hosting the Medical Device Global Expansion Forum and the Matchmaking Meeting for Global Demand of Innovative Medical Products, aiming to foster international cooperation and help enterprises expand into global markets.
3Multiple Forms of Communication:
The conference will also host concurrent events on-site.Topic Sharing, Roundtable, Launch, Boothand other forms of communication, to build a healthcare exchange and matchmaking platform that efficiently links all key resources across industry, academia, research, and investment.
Scan the QR code to register for free and learn more about the conference.